New IPO: Windlas Biotech’s IPO will come on August 4, know the special thing about this IPO

The company is one of the largest five companies of the Pharmaceuticals Formulation Contract Development and Manufacturing Organization (CDMO) in the country.

Drug formulation company Windlas Biotech will enter the IPO market on August 4 to raise Rs 401.53 crore. The company’s public issue will open for subscription on August 4 and will close on August 6. The issue price band of the company has been kept at Rs 448-460 and investors can apply in slots of at least 30 shares and multiples thereof.

Under the IPO, new shares worth Rs 165 crore will be issued and an offer for sale will be brought for 51.42 lakh equity shares.

READ REGULAR BUSINESS NEWS? CLICK HERE TO DOWNLOAD